Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems are common in lupus, often appearing first, with various types and treatments, and careful monitoring is important for diagnosis and management.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Oral ciclosporin A and topical treatments both reduce hair loss and scaling in dogs with sebaceous adenitis, but using both together is most effective.

Systemic diseases can cause hair loss, which is often reversible with treatment.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Protein-losing enteropathy worsened with lupus symptoms but improved with prednisolone.

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Effective treatments for severe alopecia areata are still lacking.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.

The mtDNA N haplogroup is linked to a higher risk of late-onset lupus and specific symptoms in Han Chinese women.

Ingesting Leucaena leucocephala caused hair loss and increased infant mortality in ringtailed lemurs.

Combining Cyclosporine A with low-dose corticosteroids effectively treats severe alopecia areata.

Finasteride microspheres help reduce hair loss for up to eight weeks with fewer side effects.

Dexpanthenol improves hair growth and satisfaction in women without side effects.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

Two patients with lupus had an unusual type of hair loss not typical for the disease but improved with treatment.

Late onset SLE has different symptoms and antibody profiles compared to young onset SLE.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Microneedling with platelet-rich plasma helps dog hair regrow faster than microneedling alone.

Systemic retinoids do not increase COVID-19 risk or severity.